Therapeutic Potentials of Curcumin for Alzheimer Disease
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many experimental preclinical pharmacological studies have demonstrated the efficacy of phytochemicals in the management of Alzheimer's disease.
“Many experimental preclinical pharmacological studies have demonstrated the efficacy of phytochemicals in the management of AD”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [79]
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Ginwala, R., Bhavsar, R., Chigbu, D. I., Jain, P., & Khan, Z. K. (2019) · Antioxidants · doi:10.3390/antiox8020035 · Cited by 613 · see citing works
“Further, curcumin inhibits the apoptosis of pre-oligodendrocyte mediated expression of iNOS, NO, and COX-2 in LPS activated microglia [125].”
BackgroundSecretase inhibitors for the treatment of Alzheimer's disease: Long road ahead
Kumar, D., Ganeshpurkar, A., Kumar, D., Modi, G. P., Gupta, S., & Singh, S. K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.035 · Cited by 170 · see citing works
Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125 · see citing works
Therapeutic potential of curcumin for multiple sclerosis
Qureshi, M., Al-Suhaimi, E. A., Wahid, F., Shehzad, O., & Shehzad, A. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3149-5 · Cited by 112 · see citing works
Redox‐Responsive Nanobiomaterials‐Based Therapeutics for Neurodegenerative Diseases
Eleftheriadou, D., Kesidou, D., Moura, F., Felli, É., & Song, W. (2020) · Small · doi:10.1002/smll.201907308 · Cited by 75 · see citing works
Kanchanatawan, B., Tangwongchai, S., Sughondhabhirom, A., Suppapitiporn, S., Hemrunrojn, S., Carvalho, A. F., & Maes, M. H. J. (2018) · Neurotoxicity Research · doi:10.1007/s12640-017-9860-4 · Cited by 71 · see citing works
“These activities targeted at the six pathophysiologically guided drug targets described in the introduction comprise: (1) attenuation of activated CMI as indicated by lowered production of interferon-γ and IL-12 and increased IL-10 production; (2) strong anti-inflammatory properties targeting nuclear factor κB (NFκB)…”
InfluentialCurcumin: Historical Background, Chemistry, Pharmacological Action, and Potential Therapeutic Value
Farooqui, T., & Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00002-5 · Cited by 60 · see citing works
Self-citationPejin, B., Tešanović, K., Jakovljević, D. M., et al. (2017) · Natural Product Research · doi:10.1080/14786419.2017.1405417 · Cited by 53 · see citing works
Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability
Uddin, M. S., & Kabir, M. T. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_5 · Cited by 49 · see citing works
Moldoveanu, C.-A., Tomoaia-Cotişel, M., Sevastre-Berghian, A., Tomoaia-Cotişel, M., Mocanu, A., Pal-Racz, C., Toma, V. A., Roman, I., Ujica, M. A., & Pop, L. C. (2024) · Molecules · doi:10.3390/molecules30010043 · Cited by 39 · see citing works
Exploiting Anti-Inflammation Effects of Flavonoids in Chronic Inflammatory Diseases
Hussain, T., Murtaza, G., Yang, H., Kalhoro, M. S., & Kalhoro, D. H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200408101550 · Cited by 37 · see citing works
Cellular Stress in the Pathogenesis of Muscular Disorders—From Cause to Consequence
Mensch, A., & Zierz, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165830 · Cited by 21 · see citing works
Cores, Á., Carmona-Zafra, N., Martín-Cámara, O., et al. (2021) · Antioxidants · doi:10.3390/antiox11010028 · Cited by 20 · see citing works
Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
Khan, F. Z., Mostaid, M. S., & Apu, M. N. H. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09874 · Cited by 20 · see citing works
Atoki, A. V., Aja, P. M., Ondari, E. N., & Shinkafi, T. S. (2023) · International Journal of Food Properties · doi:10.1080/10942912.2023.2243050 · Cited by 19 · see citing works
Kopalli, S. R., Behl, T., Kyada, A., Rekha, M. M., Kundlas, M., Rani, P., Nathiya, D., Naidu, K. S., Gulati, M., Bhise, M. R., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.02.007 · Cited by 15 · see citing works
Jafari‐Nozad, A. M., Jafari, A., Aschner, M., et al. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220817125800 · Cited by 12 · see citing works
Neurochemical Aspects of Neurological Disorders
Farooqui, A. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803603-7.00016-1 · Cited by 12 · see citing works
Self-citationTherapeutic Potentials of Curcumin in Parkinson’s Disease
Farooqui, A. A., & Farooqui, T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00018-9 · Cited by 11 · see citing works
Self-citationCurcumin Impact on Multiple Sclerosis
Qureshi, M., Al-Suhaimi, E. A., & Shehzad, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00020-7 · Cited by 11 · see citing works
Ogunsuyi, O. B., Omage, F. B., Ijomone, O. M., Oboh, G., & da Rocha, J. B. T. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14312 · Cited by 8 · see citing works
Yavtushenko, I. V., & Kostenko, V. О. (2020) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.20.1.80 · Cited by 7 · see citing works
Sharifi‐Rad, J., Almarhoon, Z. M., Adetunji, C. O., Michael, O. S., Chandran, D., Radha, R., Sharma, N., Kumar, M., & Călina, D. C. (2022) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.22.02946-7 · Cited by 7 · see citing works
Neurochemical Aspects of Neurological Disorders
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00001-3 · Cited by 5 · see citing works
Self-citationSynthesis of Anti‐Alzheimer Molecules: Bridging Chemical Approaches to Pharmaceuticals
Abbas, H., Noor, F., Khalid, S., Ahmad, M., Rasool, N., Malik, A. I., & Imran, M. (2025) · ChemistrySelect · doi:10.1002/slct.202405965 · Cited by 6 · see citing works
Potential Therapeutic Impacts of Curcumin for Improving Memory Impairment
Farooqui, T., & Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00014-1 · Cited by 5 · see citing works
Self-citationPotential Treatment Strategies of Dementia With Ayurvedic Medicines
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00009-x · Cited by 4 · see citing works
Self-citationEtemadi, A., Hemmati, S., Shahrivar‐Gargari, M., Abibiglue, Y. T., Bavili, A. S., Hamzeh‐Mivehroud, M., & Dastmalchi, S. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202300075 · Cited by 4 · see citing works
Neurochemical Aspects of Alzheimer’s Type of Dementia
Farooqui, A. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816347-4.00003-9 · Cited by 4 · see citing works
Self-citationYavtushenko, I. V., & Kostenko, V. О. (2020) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.20.2.198 · Cited by 2 · see citing works
Yavtushenko, I. V., Левков, А. А., & Kostenko, V. О. (2020) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.20.4.157 · Cited by 1 · see citing works
Nanonutraceuticals in Chemotherapy of Infectious Diseases and Cancer
Jones, S., Nallal, V. U. M., & Razia, M. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-80371-1_8 · Cited by 1 · see citing works
Molecular aspects of neurodegeneration and classification of neurological disorders
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821711-5.00001-2 · Cited by 1 · see citing works
Self-citationMehrabadi, S., Alinaghpour, A., & Zahedi, E. (2021) · International Clinical Neuroscience Journal · doi:10.34172/icnj.2021.13 · Cited by 2 · see citing works
Perspective, Summary, and Directions for Future Research on Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00010-0
Self-citationPotential Treatments for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00008-2
Self-citationMolecular mechanisms of neurodegeneration in neurodegenerative diseases
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821711-5.00004-8
Self-citationAntioxidant effects of curcumin and neuroaging
Abrahams, S., Cuttler, K., Bekker, M., Carr, J. A., Bardien, S., & Ekpo, O. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817990-1.00052-4
Neurochemical Aspects of Traumatic Brain Injury
Farooqui, A. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813596-9.00006-7
Self-citationPotential Neuroprotective Strategies for Ischemic Injuries
Farooqui, A. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813596-9.00003-1
Self-citationPotential Neuroprotective Strategies for Experimental Spinal Cord Injury
Farooqui, A. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813596-9.00005-5
Self-citation
- Authors
- Farooqui, A. A.
- Corresponding author
- Farooqui, Akhlaq A.
- Venue
- Springer eBooks
- Publisher
- Springer International Publishing
- Published
- 2016
- OpenAlex
- W2488353543
- Cited by
- 41
- References
- 0
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 3 · 2020: 8 · 2019: 9 · 2018: 5 · 2017: 4 · 2016: 1
- FWCI
- 2.69
- Type
- book
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Springer eBooks (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Keywords
- curcumin, Alzheimer's disease, dementia, neurodegenerative diseases, neuroprotection, therapeutic potential
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
